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Abstract
Background: Streptococcus intermedius is a member of the Streptococcus anginosus group. Clinical
disease with S. intermedius is characterized by abscess formation and rarely endocarditis.
Identification of Streptococcus intermedius is difficult, leading to the development of molecular
methods to more accurately identify and characterize this organism.
Case presentation: Over a period of 6 months we encountered three cases of invasive
Streptococcus intermedius infection presenting as hepatic abscesses, brain abscess, and endocarditis.
We confirmed our microbiologic diagnosis through 16S sequencing and found a common virulence
gene in each case.
Conclusion: Our report illustrates three different clinical manifestations due to Streptococcus
intermedius infection that can be encountered in healthy individuals in a community hospital setting.
To our knowledge, this is the first case of Streptococcus intermedius endocarditis confirmed by 16S
sequencing analysis. The use of molecular methods may allow a better understanding of the
epidemiology and pathogenesis of this organism.
Background
Streptococcus intermedius is a member of the Streptococcus
anginosus group (SAG), also known as the "Streptococcus
milleri" group. A variety of clinical diseases have been
associated with infection with the different members of
the SAG [1]. S. intermedius has a tendency to cause abscess
formation commonly found in the liver and brain, but is
rarely the etiologic agent in infective endocarditis [2-4].
Furthermore, members of the SAG are difficult to distin-
guish on the basis of phenotypic characteristics [1]. This
prompted the development of genotypic methods
employing the polymerase chain reaction (PCR) to aid in
the speciation of these organisms. We report three varied
cases of infection caused by S. intermedius that were
encountered over a short time period in a community-
based teaching hospital. Two cases presented with multi-
ple liver abscesses and bacteremia caused by S. interme-
dius, with one case complicated by the development of
endocarditis. The third patient presented with a brain
abscess secondary to chronic sinusitis.
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Case presentation #1
A 24 year-old male presented to his primary care physi-
cian with an 8-day history of fevers, chills, and myalgias.
He complained of a sore throat and worsening headache
with neck pain for the past 2 days. He also had abdominal
pain, constipation, and bloating throughout the week,
without nausea or vomiting. At his primary care physi-
cian's office, he had a temperature of 104°F and was sent
to the emergency department for further evaluation. On
admission, the patient was awake and oriented, but
appeared lethargic and pale. Vital signs included a temper-
ature of 103°F, blood pressure of 112/51 mmHg, pulse of
112/minute, respiratory rate of 22/minute, and an oxygen
saturation of 88% on room air. The physical exam
revealed minimal crackles at the lung bases and mid-
abdominal tenderness without peritoneal signs or hepat-
osplenomegaly. The rest of the physical exam was unre-
markable. Laboratory data included a white blood count
of 14,900/μL with 77% neutrophils and 10% bands,
hemoglobin of 14.9 gm/dL, platelet count of 244,000/
cmm, and a C-reactive protein of 39.9 mg/L. Liver
enzymes, BUN, creatinine, and electrolyte panel were
within normal limits. A monospot and influenza A and B
were negative. A lumber puncture performed in the emer-
gency department did not show evidence of meningitis. A
chest x-ray showed a left basilar infiltrate.
The patient was initially treated for community-acquired
pneumonia with ceftriaxone 2 g once daily and azithro-
mycin 500 mg once daily. Blood cultures drawn on
admission grew viridans group streptococci, and azithro-
mycin was discontinued. A transesophageal echocardio-
gram showed vegetation on the anterior leaflet of the
mitral valve (Figure 1), and ceftriaxone was continued for
treatment of endocarditis. A CT scan of the abdomen per-
formed due to persistent abdominal pain revealed multi-
ple liver abscesses. One of the abscesses was drained
percutaneously under CT guidance. Cultures of the aspi-
rate also grew only viridans group streptococci. Anaerobic
cultures were negative. The patient continued to spike
fevers, and antibiotics were changed to penicillin 24 mil-
lion units a day and low dose gentamicin. Repeat blood
cultures were negative. However, the patient remained
febrile and tachycardic with increasing leukocytosis.
Because of worsening clinical status, he required addi-
tional percutaneous drainage of three more abscesses.
After six months of antibiotic therapy, the patient is doing
well with significant clinical improvement.
Case presentation #2
A 53 year-old female presented to the emergency depart-
ment with fevers and chills for 12 days. Two days prior to
admission, she had nausea, vomiting, and diarrhea. She
denied abdominal pain, hematemesis, or hematochezia.
She reported a 30 lb weight loss in the past six months,
which she attributed to her new job. She drank 1–2 mixed
drinks of vodka a day but denied problems with alcohol
intoxication or withdrawal. On admission, the patient
was alert and oriented, but appeared ill. Vital signs
revealed a temperature of 102.5°F, blood pressure of 115/
65, pulse 78/minute, and respiratory rate of 20/minute.
Physical exam demonstrated right upper quadrant tender-
ness without distention, guarding, or rebound. The rest of
her physical exam was unremarkable. Laboratory data
showed a white blood count of 16,000/μL with 89% neu-
trophils and 1% bands, hemoglobin of 11.9 g/dL, plate-
lets of 361,000/L, alkaline phosphatase of 220 units/L,
bilirubin of 2.5 mg/dL, ALT of 51 units/L, and AST of 56
units/L. Amylase, lipase, electrolyte panel, BUN, and cre-
atinine were within normal limits. A CT scan of the abdo-
men and pelvis showed multiple liver lesions with the
largest measuring 10 cm by 9.9 cm with gallbladder wall
thickening (Figure 2). An echocardiogram was not per-
formed.
The patient was started on imipenem 500 mg every 8
hours. General surgery was consulted and performed an
exploratory laparotomy with surgical drainage of 4
abscesses and a cholecystectomy. Blood cultures on
admission grew viridans group streptococci. Surgical cul-
tures also grew viridans group streptococci with negative
anaerobic cultures. The antibiotic regimen was changed to
ceftriaxone 2 g once daily. The patient continued to follow
up with the Infectious Diseases Clinic. After a total of 6
months of cephalosporin therapy, repeat CT scan of the
abdomen showed resolution of the liver abscesses.
Transesophageal echocardiogram image of the mitral valve  showing a highly mobile linear echodensity on the ventricular  side of the mitral leaflet Figure 1
Transesophageal echocardiogram image of the 
mitral valve showing a highly mobile linear echoden-
sity on the ventricular side of the mitral leaflet.BMC Infectious Diseases 2008, 8:154 http://www.biomedcentral.com/1471-2334/8/154
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Case presentation #3
A 16 year-old female with a history of chronic sinusitis
presented with worsening frontal headache and frequent
episodes of bloody sinus drainage over a period of six
months. She was placed on antihistamines and steroid
nasal spray without relief. The patient had difficulty con-
centrating in school and was started on atomoxetine for
possible ADHD. She denied fevers, decreased level of con-
sciousness, and focal neurological signs. An outpatient CT
of the brain showed a left frontal mass, and complete
opacification of the bilateral frontal, bilateral ethmoid,
left maxillary, and right sphenoid sinuses. An MRI was
performed which showed a thick-walled, ring-enhancing,
frontal abscess, reflecting as an intracranial extension of a
large mucocele. She was subsequently sent to the emer-
gency department for further evaluation. Vital signs
include a temperature of 97°F, blood pressure of 117/75,
pulse 84/minute, and respiratory rate of 14/minute. Phys-
ical exam was unremarkable with a GCS of 15 and no neu-
rological deficits. Laboratory data showed a white blood
count of 8,100/μL, hemoglobin of 12.5 g/dL, and platelets
of 435,000/L. Electrolyte panel, liver function tests, BUN,
and creatinine were within normal limits. She was placed
on ceftriaxone 2 g every 12 hours and metronidazole 500
mg every 6 hours.
On the following day, the patient had a bifrontal craniot-
omy with evacuation of the abscess and cranialization of
the frontal sinuses. Pathology of the surgical specimen
revealed abscess and granulation tissue with acute and
chronic inflammation. A gram stain of the brain tissue
showed gram positive cocci in chains (Figure 3). Cultures
from the surgical drainage grew viridans group strepto-
cocci with negative anaerobic cultures. Because of the
extent and severity of the sinusitis, the patient underwent
bilateral ethmoidectomy, bilateral maxillary antrostomy,
left sphenoidotomy, and left concha bullosa resection.
The patient finished an 8-week course of ceftriaxone mon-
otherapy. A repeat MRI of the brain showed resolution of
the frontal abscess.
Microbiologic diagnosis
Written consent was obtained from all patients. Michigan
State University's Institutional Review Board has waived
the need for approval.
Direct Gram stain of the abscess drainage of all three
patients and positive blood cultures revealed Gram-posi-
tive cocci in chains. Cultures on sheep blood agar pro-
duced alpha-hemolytic colonies of Gram-positive cocci
after 24 hours of incubation at 37°C. The isolates were
presumptively identified as members of the Streptococcus
anginosus group by phenotypic classification [5]. Antibi-
otic susceptibility testing was performed by E-test on both
blood and abscess drainage cultures. The isolate of case #1
was susceptible to penicillin (MIC ≤ 0.12 mg/L), ceftriax-
one (MIC ≤ 0.12), cefotaxime (MIC ≤ 1.25), and vanco-
mycin. The isolate was resistant to erythromycin and
clindamycin. The blood and surgical abscess drainage cul-
tures of case #2 revealed similar susceptibility patterns in
that the isolate was susceptible to penicillin (MIC ≤
0.032), ceftriaxone (MIC ≤ 0.064), and vancomycin with
resistance to erythromycin and clindamycin. Tetracycline
was not tested in both cases. The isolate from the brain
CT scan of the abdomen with contrast of Case 2 showing a  large, loculated liver abscess measuring 10 cm Figure 2
CT scan of the abdomen with contrast of Case 2 
showing a large, loculated liver abscess measuring 10 
cm.
Gram stain of brain tissue from Case 3 showing gram posi- tive cocci in chains Figure 3
Gram stain of brain tissue from Case 3 showing gram 
positive cocci in chains.BMC Infectious Diseases 2008, 8:154 http://www.biomedcentral.com/1471-2334/8/154
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abscess of case #3 did not have adequate growth to per-
form antibiotic susceptibilities.
Using the primer pair 8F and 1492R and the genomic
DNA from each isolate, a nearly complete (> 1.4 kbp) 16S
rRNA gene fragment was amplified by conventional PCR
[6]. For each isolate, the partial 16S rRNA-encoding gene
sequence was 100% identical to the type strain of S. inter-
medius (GenBank accession number AF104671). In addi-
tion, all three isolates were positive in a PCR assay
targeting the ily gene, which encodes for S. intermedius
toxin intermedilysin [7].
Discussion
The Streptococcus anginosus group (SAG), one of five
groups collectively known as viridans group streptococci,
consists of the species S. intermedius, S. anginosus, and S.
constellatus [8]. These organisms are commonly associated
with purulent infections with abscess formation and less
commonly the cause of endocarditis than other viridans
streptococci [9-13]. S. intermedius has an apparent tropism
for the brain and liver, whereas S. anginosus and S. constel-
latus have been isolated from a wider range of sites and
infections [2,14]. The three cases presented here highlight
a common presentation of S. intermedius (liver and brain
abscesses) and a rare complication (endocarditis).
The identification and classification of streptococci based
on hemolytic and Lancefield grouping reactions is cum-
bersome and lacks discriminatory power. Whiley, et. al.
developed phenotypic methods to better differentiate the
SAG[14]. Commercially available systems based on these
phenotypic tests are widely used and provide a more rapid
characterization of each species, but accuracy remains var-
iable [15,16]. This has led to the development of molecu-
lar techniques, such as PCR sequencing, to increase the
accuracy of identification and clinical profiling
[1,7,17,18]. Furthermore, several species-specific genes
have been targeted for the development of PCR-based
assays for the identification of the SAG organisms [7,18].
Intermedilysin (ILY) is a human-specific cytolysin that
directly damages human hepatic cells and is implicated as
a potential important virulence factor in causing deep-
seated abscesses [19]. The ily gene has been shown to be
specific for S. intermedius. The assay can be used for rapid
identification through the use of PCR with the ily gene as
a species marker gene, which was amplified on all three
isolates [7].
Pyogenic liver abscesses are an uncommon, but poten-
tially life-threatening, infection. The first cases of SAG
hepatic abscesses were reported in 1975 [20]. Later, a
study in 1981 found SAG to be the most common cause
of hepatic abscesses [21]. A prospective study by
Coreedoira, et. al. compared the incidence and clinical
features of SAG liver abscess to liver abscesses caused by
other organisms. Members of SAG were most commonly
isolated, with S. intermedius being the most frequent spe-
cies. Abscesses also tended to be monomicrobial and the
duration of symptoms were longer when compared to
other organisms. However, there were no differences in
mortality, duration of antibiotics, or complications. The
majority of patients required surgical or percutaneous
drainage of the abscesses for cure as was the case for our
patients, whereas 20% of patients were treated with anti-
microbials alone [22].
Members of the SAG are rare causes of endocarditis. Previ-
ous studies on infective endocarditis caused by SAG have
relied on phenotypic methods for identification. Suss-
man, et. al. studied 36 patients with viridans streptococcal
endocarditis, and identification at the species level was
determined by using biochemical tests established by
Facklam [23]. Four of the cases were found to be S. inter-
medius. Sixteen isolates from the study were sent to five
institutions to confirm identification. Not surprisingly,
only 3 were characterized as the same species by all five
institutions [24]. Another retrospective study found 29
cases of endocarditis due to SAG, and only 3 were identi-
fied as S. intermedius [25]. However, the commercial
method used in this case, Rapid 32 ID Strep System
(bioMérieux), has been shown to be the least accurate in
identifying S. intermedius [16]. A more recent study by
Woo, et. al. applied 16S rRNA sequencing to 6 cases of
SAG endocarditis, all of which were identified as S. angi-
nosus [3]. To our knowledge, we report the first case of S.
intermedius endocarditis confirmed by 16S sequence anal-
ysis.
Brain abscesses can result via spread from a contiguous
focus of infection, hematogenous spread, or as a result
from head trauma or neurosurgery [26]. Mortality and
morbidity have reduced over the decades in the advent of
newer antibiotic therapies and early recognition with CT
scans and MRIs [27]. Several case series have defined the
clinical characteristics of patients with brain abscesses. All
ages are affected with a male predominance. Headache,
fever, and mental status changes are the most common
initial presenting features, although only one-third of
patients have the classic triad. The majority of abscesses
are solitary and occur in the frontal lobe. Surgery is
required in most patients, and the duration of antibiotics
range from 4 to 8 weeks [26-31]. The SAG has been
recently recognized as a common cause of brain abscesses,
which were collectively identified with other streptococci
as viridans group streptococci in prior studies [29,31].
Several retrospective reviews and case reports have identi-
fied S. intermedius as a significant pathogen among the
SAG in the development of brain abscesses [1,2,32,33].
However, no study has compared S. intermedius brainBMC Infectious Diseases 2008, 8:154 http://www.biomedcentral.com/1471-2334/8/154
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abscesses with other members of the SAG or with other
bacterial causes.
A unique feature of our cases was the lack of underlying
medical problems in our two patients with liver abscesses.
Infections caused by SAG are not common in previously
healthy individuals. An underlying condition, such as dia-
betes, cirrhosis, or cancer, is associated with the majority
of patients [12,34,35]. Neither of our patients with liver
abscesses had chronic illnesses or evidence of immuno-
suppression. The third case with brain abscess, however,
had chronic sinusitis, which is one of the most common
predisposing factors [29,31]. The presentation of these
cases highlights the range of infection caused by S. inter-
medius that can be encountered in a community setting.
Our findings indicate that infections with S. intermedius
and the other members of the SAG may be more common
that previously appreciated.
Conclusion
S. intermedius commonly causes liver and brain abscesses
but rarely endocarditis. Our cases demonstrate how S.
intermedius can cause severe illness in otherwise healthy
individuals. Because species in the Streptococcus angino-
sus group are difficult to identify by routine biochemical
tests, newer molecular methods are available to more
accurately identify each species. As newer genotyping
techniques develop, the clinical characteristics of this
diverse group are becoming better understood. These
three cases highlight both common and uncommon pres-
entations of S. intermedius infection and the utilization of
these methods to confirm a rare case of S. intermedius
endocarditis. Additional studies will be required to more
precisely determine the prevalence and range of clinical
disease due to infection with the SAG organisms.
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